Oelschlager Kristen M sold CSTL
September 1, 2026 · Form 4 insider transaction
Oelschlager Kristen M sold 200 shares of Castle Biosciences, Inc. at $34.02 per share, a transaction worth $6.8K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
200
Price
$34.02
Total value
$6.8K
InsiderOelschlager Kristen M
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateSeptember 1, 2026
Filing dateSeptember 3, 2026
Shares owned after13,356
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, on March 17, 2026.